These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3531027)

  • 1. [In vitro activity and resistance of 4-quinolones].
    Bauernfeind A
    Infection; 1986; 14 Suppl 3():S186-7. PubMed ID: 3531027
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinolones: pharmacology.
    Verbist L
    Pharm Weekbl Sci; 1986 Feb; 8(1):22-5. PubMed ID: 3008075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gyrase inhibitor].
    Forth W
    Klin Wochenschr; 1985 Oct; 63(19):1036-9. PubMed ID: 2999503
    [No Abstract]   [Full Text] [Related]  

  • 4. Mode of action, and in vitro and in vivo activities of the fluoroquinolones.
    Fernandes PB
    J Clin Pharmacol; 1988 Feb; 28(2):156-68. PubMed ID: 3283179
    [No Abstract]   [Full Text] [Related]  

  • 5. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.
    Wolfson JS; Hooper DC
    Antimicrob Agents Chemother; 1985 Oct; 28(4):581-6. PubMed ID: 3000292
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to ciprofloxacin.
    Chapman ST; Speller DC; Reeves DS
    Lancet; 1985 Jul; 2(8445):39. PubMed ID: 2861478
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial resistance to fluoroquinolones.
    Neu HC
    Rev Infect Dis; 1988; 10 Suppl 1():S57-63. PubMed ID: 3279500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acrosoxacin resistance in Neisseria gonorrhoeae.
    Macaulay ME
    Lancet; 1982 Jan; 1(8264):171-2. PubMed ID: 6119550
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro effect of rosoxacin on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Le Van Thoi J; Chanal M; Cluzel M; Fleurette J; Forey F; Thabaut A; Meyran M; Vandekerkove M; Sicard D; Acar JF; Kitzis MD; Veron M; Fauchere JL
    Pathol Biol (Paris); 1983 Jun; 31(6):504-8. PubMed ID: 6348657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthetic chemotherapeutic agents V. Antibacterial activities of thiazolo[5,4-f]quinolinecarboxylic acid derivatives (author's transl)].
    Kadoya S; Nagasaki S
    Yakugaku Zasshi; 1979 May; 99(5):483-92. PubMed ID: 544775
    [No Abstract]   [Full Text] [Related]  

  • 11. The mode of action of 4-quinolones and possible mechanisms of resistance.
    Smith JT
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():21-9. PubMed ID: 3542946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates.
    Xicota MA; Coll R; Esteve M; Moros M; Parés J
    Drugs Exp Clin Res; 1987; 13(3):133-6. PubMed ID: 3622242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acrosoxacin-resistant gonococci.
    Jones C; Cohen L
    Lancet; 1982 Apr; 1(8276):855-6. PubMed ID: 6122085
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of four new quinolones in Mueller-Hinton broth and peritoneal dialysis fluid.
    Weissauer-Condon C; Engels I; Daschner FD
    Eur J Clin Microbiol; 1987 Jun; 6(3):324-6. PubMed ID: 3622502
    [No Abstract]   [Full Text] [Related]  

  • 15. The quinolones and dermatologic practice.
    Parish LC; Witkowski JA
    Int J Dermatol; 1986; 25(6):351-6. PubMed ID: 3531041
    [No Abstract]   [Full Text] [Related]  

  • 16. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. b. Synthetic antibacterial agents].
    Ohno I; Ida S
    Nihon Rinsho; 1987 Mar; 45(3):577-82. PubMed ID: 3298736
    [No Abstract]   [Full Text] [Related]  

  • 17. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
    Neu HC
    J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of action of quinolones].
    Smith JT
    Infection; 1986; 14 Suppl 1():S3-15. PubMed ID: 2420724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacterial activity in vitro of 10 quinolones against 20 strains of Legionella pneumophila].
    Deforges L; Fournet MP; Soussy CJ; Duval J
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):631-3. PubMed ID: 3534757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of pefloxacin compared with six other quinolones.
    Ligtvoet EE; Wickerhoff-Minoggio T
    J Antimicrob Chemother; 1985 Oct; 16(4):485-90. PubMed ID: 3864776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.